Can ebselen prevent cisplatin-induced ovarian damage?
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.297, no.6, pp.1549-1555, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 297 Issue: 6
- Publication Date: 2018
- Doi Number: 10.1007/s00404-018-4750-4
- Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1549-1555
- Istanbul University Affiliated: Yes
Abstract
Purpose The occurrence of ovarian damage is a major shortcoming in treating tumors with cisplatin (CP). The present study investigates the beneficial effects of ebselen-a seleno-organic compound with antioxidant and antiinflammatory properties-vis-a-vis CP-induced ovarian damage.